Leukemia

LEUKEMIA NEWS TIPS & FEATURES

Progress Reported in New Treatments for People with Lymphoma

December 29th, 2016

Progress Reported in New Treatments for People with Lymphoma

Research and pharmaceutical executives unveil encouraging clinical trial data at the annual meeting of the American Society of Hematology. Twenty-two years ago, Dr. Gary Gordon, […]


FDA Grants Iclusig® Expanded Approval for CML

December 14th, 2016

FDA Grants Iclusig® Expanded Approval for CML

The United States Food and Drug Administration (FDA) has granted Iclusig® (ponatinib) approval to treat all phases of chronic myeloid leukemia (CML) in adults, as […]


UCLA Identifies Potential Cancer Treatment with Fewer Side Effects Than Chemotherapy

December 12th, 2016

UCLA Identifies Potential Cancer Treatment with Fewer Side Effects Than Chemotherapy

By Stuart Wolpert, UCLA Asynthetic version of a rare toxin produced by a sea creature appears to hold promise for treating many different types of […]


Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

December 1st, 2016

Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring […]


Useful Definitions for Chronic Myelogenous Leukemia (CML)

November 16th, 2016

Useful Definitions for Chronic Myelogenous Leukemia (CML)

Blood stem cell: An immature cell from which other types of blood cells develop. Bone marrow: The soft, sponge-like tissue in the center of most […]


FDA Priority Review Granted for Midostaurin in Leukemia

November 15th, 2016

FDA Priority Review Granted for Midostaurin in Leukemia

The United States Food and Drug Administration (FDA) has granted priority review to PKC412 (midostaurin) in the treatment of newly diagnosed acute myeloid leukemia (AML) […]


Discovery of Ezh2 May Represent New Treatment Option for Chronic Myelogenous Leukemia

November 3rd, 2016

Discovery of Ezh2 May Represent New Treatment Option for Chronic Myelogenous Leukemia

Each year in the United States, approximately 5,000 people are diagnosed with CML. Most cases of CML are characterized by a chromosomal abnormality—the Philadelphia chromosome—in […]


LLS Launches Groundbreaking Precision Medicine Approach To Treat AML

November 1st, 2016

LLS Launches Groundbreaking Precision Medicine Approach To Treat AML

Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) announced the launch of a groundbreaking, […]


High Up-Front Costs Could Delay Access to Life-Saving Blood Cancer Drugs for Medicare Patients

October 18th, 2016

High Up-Front Costs Could Delay Access to Life-Saving Blood Cancer Drugs for Medicare Patients

Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients’ treatment with a novel class of […]


Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

September 26th, 2016

Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

Acccording to results recently published in the New England Journal of Medicine, young adults with CD20-positive, Philadelphia chromosome  (PH)-negative acute lymphoblastic leukemia (ALL), experience survival […]


More News →